BROS vs INBX · P/E 105, rev $1.02B vs rev $1.3M
Dutch Bros Inc (BROS) versus Inhibrx Biosciences, Inc. (INBX) — a side-by-side from cached financials, not a winner call.
Dutch Bros Inc (BROS) is a restaurants company listed on NYSE.
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
Latest reported BROS revenue for 2026-06-30 was $1.02B. Net income was $53.5M. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
BROS currently screens at market cap $11.74B and trailing P/E 105.0. INBX currently screens at market cap $1.28B.
Not investment advice. Open the BROS and INBX stock pages for the full models.
Not investment advice.